Search research articles
Contact Us
Filters
Showing results (851-860 of 920) with videos related to
Page
of 92
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial
Vivek Subbiah, Pete M Anderson, Kalevi Kairemo, et al.
Scientific Reports
|
August 27, 2017
Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients
Gustavo Schvartsman, Michael J Wagner, Behrang Amini, et al.
Cancer
|
September 5, 2002
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas
Funda Meric, Kenneth R Hess, Datla G K Varma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2018
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Vivek Subbiah, Ravi Murthy, David S Hong, et al.
Cancer
|
October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)
L G Feun, J Gutterman, M A Burgess, et al.
Journal of Surgical Oncology
|
June 18, 2019
The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum
John S A Chrisinger, Tariq Al-Zaid, Emily Z Keung, et al.
Cell Metabolism
|
May 18, 2022
Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling
Daniel I Benjamin, Pieter Both, Joel S Benjamin, et al.
Scientific Reports
|
November 23, 2017
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors
Vikas Dembla, Roman Groisberg, Ken Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
Michael C Heinrich, Kouros Owzar, Christopher L Corless, et al.
Annals of Surgical Oncology
|
October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Robert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Page
of 92
Search research articles
Search
Showing results (851-860 of 920) with videos related to
Sort By:
Page
of 92
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial
Vivek Subbiah, Pete M Anderson, Kalevi Kairemo, et al.
Scientific Reports
|
August 27, 2017
Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients
Gustavo Schvartsman, Michael J Wagner, Behrang Amini, et al.
Cancer
|
September 5, 2002
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas
Funda Meric, Kenneth R Hess, Datla G K Varma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2018
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Vivek Subbiah, Ravi Murthy, David S Hong, et al.
Cancer
|
October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)
L G Feun, J Gutterman, M A Burgess, et al.
Journal of Surgical Oncology
|
June 18, 2019
The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum
John S A Chrisinger, Tariq Al-Zaid, Emily Z Keung, et al.
Cell Metabolism
|
May 18, 2022
Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling
Daniel I Benjamin, Pieter Both, Joel S Benjamin, et al.
Scientific Reports
|
November 23, 2017
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors
Vikas Dembla, Roman Groisberg, Ken Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
Michael C Heinrich, Kouros Owzar, Christopher L Corless, et al.
Annals of Surgical Oncology
|
October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Robert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Page
of 92